183 related articles for article (PubMed ID: 24373225)
21. Evaluation of the efficacy and safety of Escherichia coli-derived recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion to treat degenerative spinal disease: a protocol of prospective, randomized controlled, assessor-blinded, open-label, multicenter trial.
Choi JY; Park HJ; Park SM; Kang CN; Song KS
J Orthop Surg Res; 2022 Aug; 17(1):397. PubMed ID: 36045371
[TBL] [Abstract][Full Text] [Related]
22. Pseudo-Pedicle Heterotopic Ossification From Use of Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) in Transforaminal Lumbar Interbody Fusion Cages.
Rosen CD; Kiester PD; Lee TQ
Am J Orthop (Belle Mead NJ); 2018 Jan; 47(1):. PubMed ID: 29447305
[TBL] [Abstract][Full Text] [Related]
23. Retrograde ejaculation following single-level anterior lumbar surgery with or without recombinant human bone morphogenetic protein-2 in 5 randomized controlled trials: clinical article.
Burkus JK; Dryer RF; Peloza JH
J Neurosurg Spine; 2013 Feb; 18(2):112-21. PubMed ID: 23199378
[TBL] [Abstract][Full Text] [Related]
24. Graft resorption with the use of bone morphogenetic protein: lessons from anterior lumbar interbody fusion using femoral ring allografts and recombinant human bone morphogenetic protein-2.
Pradhan BB; Bae HW; Dawson EG; Patel VV; Delamarter RB
Spine (Phila Pa 1976); 2006 May; 31(10):E277-84. PubMed ID: 16648733
[TBL] [Abstract][Full Text] [Related]
25. Vertebral osteolysis originating from subchondral cyst end plate defects in transforaminal lumbar interbody fusion using rhBMP-2. Report of two cases.
Balseiro S; Nottmeier EW
Spine J; 2010 Jul; 10(7):e6-e10. PubMed ID: 20488766
[TBL] [Abstract][Full Text] [Related]
26. Anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2: a prospective study of complications.
Malham GM; Parker RM; Ellis NJ; Blecher CM; Chow FY; Claydon MH
J Neurosurg Spine; 2014 Dec; 21(6):851-60. PubMed ID: 25279655
[TBL] [Abstract][Full Text] [Related]
27. Heterotopic bone formation with the use of rhBMP2 in posterior minimal access interbody fusion: a CT analysis.
Joseph V; Rampersaud YR
Spine (Phila Pa 1976); 2007 Dec; 32(25):2885-90. PubMed ID: 18246013
[TBL] [Abstract][Full Text] [Related]
28. Histologic evaluation of the efficacy of rhBMP-2 compared with autograft bone in sheep spinal anterior interbody fusion.
Sandhu HS; Toth JM; Diwan AD; Seim HB; Kanim LE; Kabo JM; Turner AS
Spine (Phila Pa 1976); 2002 Mar; 27(6):567-75. PubMed ID: 11884903
[TBL] [Abstract][Full Text] [Related]
29. Complications with the use of bone morphogenetic protein 2 (BMP-2) in spine surgery.
Tannoury CA; An HS
Spine J; 2014 Mar; 14(3):552-9. PubMed ID: 24412416
[TBL] [Abstract][Full Text] [Related]
30. Bone morphogenetic protein use in spine surgery-complications and outcomes: a systematic review.
Faundez A; Tournier C; Garcia M; Aunoble S; Le Huec JC
Int Orthop; 2016 Jun; 40(6):1309-19. PubMed ID: 26961193
[TBL] [Abstract][Full Text] [Related]
31. Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 1: Large series diagnosis related outcomes and complications with 2- to 9-year follow-up.
Crandall DG; Revella J; Patterson J; Huish E; Chang M; McLemore R
Spine (Phila Pa 1976); 2013 Jun; 38(13):1128-36. PubMed ID: 23370679
[TBL] [Abstract][Full Text] [Related]
32. Use of polyetheretherketone spacer and recombinant human bone morphogenetic protein-2 in the cervical spine: a radiographic analysis.
Klimo P; Peelle MW
Spine J; 2009 Dec; 9(12):959-66. PubMed ID: 19574105
[TBL] [Abstract][Full Text] [Related]
33. Radiographic Appearance of Transforaminal Lumbar Interbody Fusion Performed With and Without Recombinant Human Morphogenetic Protein-2.
Stensby JD; Kaliney RW; Alford B; Shen FH; Patrie JT; Fox MG
AJR Am J Roentgenol; 2016 Mar; 206(3):588-94. PubMed ID: 26901016
[TBL] [Abstract][Full Text] [Related]
34. Bone Morphogenetic Proteins in Spinal Surgery: What Is the Fusion Rate and Do They Cause Cancer?
Malham GM; Giles GG; Milne RL; Blecher CM; Brazenor GA
Spine (Phila Pa 1976); 2015 Nov; 40(22):1737-42. PubMed ID: 26730525
[TBL] [Abstract][Full Text] [Related]
35. Vertebral bone resorption after transforaminal lumbar interbody fusion with bone morphogenetic protein (rhBMP-2).
McClellan JW; Mulconrey DS; Forbes RJ; Fullmer N
J Spinal Disord Tech; 2006 Oct; 19(7):483-6. PubMed ID: 17021411
[TBL] [Abstract][Full Text] [Related]
36. Instrumented one and two level posterolateral fusions with recombinant human bone morphogenetic protein-2 and allograft: a computed tomography study.
Stambough JL; Clouse EK; Stambough JB
Spine (Phila Pa 1976); 2010 Jan; 35(1):124-9. PubMed ID: 20042965
[TBL] [Abstract][Full Text] [Related]
37. Radiographic assessment of interbody fusion using recombinant human bone morphogenetic protein type 2.
Burkus JK; Dorchak JD; Sanders DL
Spine (Phila Pa 1976); 2003 Feb; 28(4):372-7. PubMed ID: 12590213
[TBL] [Abstract][Full Text] [Related]
38. RhBMP-2 versus iliac crest bone graft for lumbar spine fusion: a randomized, controlled trial in patients over sixty years of age.
Glassman SD; Carreon LY; Djurasovic M; Campbell MJ; Puno RM; Johnson JR; Dimar JR
Spine (Phila Pa 1976); 2008 Dec; 33(26):2843-9. PubMed ID: 19092613
[TBL] [Abstract][Full Text] [Related]
39. The use of recombinant human bone morphogenetic protein 2 (rhBMP-2) to promote spinal fusion in a nonhuman primate anterior interbody fusion model.
Hecht BP; Fischgrund JS; Herkowitz HN; Penman L; Toth JM; Shirkhoda A
Spine (Phila Pa 1976); 1999 Apr; 24(7):629-36. PubMed ID: 10209790
[TBL] [Abstract][Full Text] [Related]
40. Comparison of transforaminal and posterior lumbar interbody fusion outcomes in patients receiving a novel allograft versus rhBMP-2: a radiographic and patient-reported outcomes analysis.
Hani U; Farber SH; Pfortmiller D; Kim PK; Bohl MA; Holland CM; McGirt MJ
J Neurosurg Spine; 2024 May; ():1-10. PubMed ID: 38759243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
